Data / Form D filings / Artin Bioscience Inc.
Artin Bioscience Inc.: Form D filing
Artin Bioscience Inc., a pharmaceuticals company in Denver, CO, filed a Form D with the SEC in 2023. The latest, on March 13, 2023, reports $482,500 sold of a $482,500 offering.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700 WEST 11TH STREET, Denver, CO, 80204
- Phone
- (312) 771-2671
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1968329
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | New notice | $482,500 | $482,500 | 0 | Mar 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Doyle | Executive Officer, Director | |
| Erik Eglite | Executive Officer, Director | |
| Charles Magolske | Executive Officer, Director | |
| Norbert Voelkel | Director |
Every Form D from the week of Mar 13, 2023 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Artin Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.